Literature DB >> 26092320

Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

Riccardo Valdagni1, Hendrik Van Poppel2, Michael Aitchison3, Peter Albers4, Dominik Berthold5, Alberto Bossi6, Maurizio Brausi7, Louis Denis8, Lawrence Drudge-Coates9, Maria De Santis10, Günther Feick11, Chris Harrison12, Karin Haustermans13, Donal Hollywood14, Morton Hoyer15, Henk Hummel16, Malcolm Mason17, Vincenzo Mirone18, Stefan C Müller19, Chris Parker20, Mahasti Saghatchian21, Cora N Sternberg22, Bertrand Tombal23, Erik van Muilekom24, Maggie Watson25, Simone Wesselmann26, Thomas Wiegel27, Tiziana Magnani28, Alberto Costa29.   

Abstract

The Prostate Cancer Programme of the European School of Oncology developed the concept of specialised interdisciplinary and multiprofessional prostate cancer care to be formalized in Prostate Cancer Units (PCU). After the publication in 2011 of the collaborative article "The Requirements of a Specialist Prostate Cancer Unit: A Discussion Paper from the European School of Oncology", in 2012 the PCU Initiative in Europe was launched. A multiprofessional Task Force of internationally recognized opinion leaders, among whom representatives of scientific societies, and patient advocates gathered to set standards for quality comprehensive prostate cancer care and designate care pathways in PCUs. The result was a consensus on 40 mandatory and recommended standards and items, covering several macro-areas, from general requirements to personnel to organization and case management. This position paper describes the relevant, feasible and applicable core criteria for defining PCUs in most European countries delivered by PCU Initiative in Europe Task Force.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Minimal requirement; Multidisciplinary and multiprofessional approach; Prostate cancer; Prostate cancer unit

Mesh:

Year:  2015        PMID: 26092320     DOI: 10.1016/j.critrevonc.2015.05.014

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.

Authors:  Emilio Bombardieri; L Evangelista; G L Ceresoli; F Boccardo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-18       Impact factor: 9.236

2.  [Improved prostate cancer treatment in certified centers : Is the strategic vision realistic?].

Authors:  J Steffens; J Kranz; P Albers
Journal:  Urologe A       Date:  2015-11       Impact factor: 0.639

3.  GUROPA survey: genito-urinary radiation oncology prescription attitudes.

Authors:  Sergio Fersino; Stefano Arcangeli; Barbara Alicja Jereczek-Fossa; Rolando D'Angelillo; Filippi Bertoni; Giuseppe Roberto D'Agostino; Luca Triggiani; Renzo Corvò; Stefano Maria Magrini; Filippo Alongi
Journal:  Radiol Med       Date:  2018-07-13       Impact factor: 3.469

Review 4.  THE PROSTATE CENTER: MULTIDISCIPLINARITY, ORGANIZATION OF DIAGNOSTIC WORK-UP AND TREATMENT OF PROSTATE CANCER.

Authors:  Tomislav Kuliš; Luka Penezić; Marija Gamulin; Ivica Mokos; Marjan Marić; Vladimir Ferenčak; Eleonora Goluža; Tvrtko Hudolin; Željko Kaštelan
Journal:  Acta Clin Croat       Date:  2019-11       Impact factor: 0.780

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.